Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) commonly prescribed to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain. In the context of cancer, duloxetine has shown efficacy in managing chemotherapy-induced peripheral neuropathy (CIPN), a painful and often debilitating side effect of certain chemotherapy treatments.